{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:00:27Z","timestamp":1790845227877,"version":"4.1.0"},"reference-count":31,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Sarcopenia, low muscle mass, and low muscle radiodensity are increasingly being considered factors associated with treatment outcomes in patients with gynecological malignancies. Despite the growing body of evidence, body composition assessment is not routinely incorporated into clinical practice. The aim of this review was to present current evidence on the associations of muscle parameters with survival, complications, systemic treatment toxicity, and quality of life, as well as to discuss the opportunities and limitations of computed tomography (CT) and bioelectrical impedance analysis (BIA) in body composition monitoring. A narrative literature review was conducted using the PubMed, Scopus, and Web of Science databases, primarily covering publications from 2019 to 2026, together with earlier studies relevant to the topic. Systematic reviews, meta-analyses, and selected observational, longitudinal, and interventional studies were included. The available evidence indicates that low muscle mass and low muscle radiodensity are primarily associated with poorer overall survival and an increased risk of selected postoperative complications. Evidence regarding progression-free survival, disease recurrence, chemotherapy toxicity, and quality of life remains less consistent. Low muscle mass may occur independently of body weight and body mass index (BMI); therefore, routine anthropometric assessment may fail to identify adverse changes in body composition. CT image analysis enables quantitative assessment of muscle mass and evaluation of muscle radiodensity, whereas BIA may serve as a complementary tool for repeated body composition monitoring. However, its use is limited by the effects of hydration status, edema, and ascites, as well as by the lack of validated cut-off values for patients with gynecological malignancies. Body composition assessment should be interpreted in conjunction with evaluations of muscle strength, physical performance, nutritional status, treatment toxicity, and quality of life. Prospective studies are needed to determine whether body composition monitoring and the implementation of targeted supportive care improve treatment tolerance and clinical outcomes.<\/jats:p>","DOI":"10.3390\/cancers18193164","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:19:08Z","timestamp":1790842748000},"page":"3164","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond BMI: The Clinical Relevance of Sarcopenia and Muscle Quality in Gynecologic Oncology from Meta-Analyses to Practice\u2014The Potential Role of Body Composition Assessment, Including BIA, in Supportive Care"],"prefix":"10.3390","volume":"18","author":[{"given":"Beata","family":"Pi\u0119ta","sequence":"first","affiliation":[{"name":"Department of Practical Midwifery Education, Poznan University of Medical Sciences, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Gajewska","sequence":"additional","affiliation":[{"name":"Department of Practical Midwifery Education, Poznan University of Medical Sciences, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Miko\u0142ajczyk","sequence":"additional","affiliation":[{"name":"Department of Practical Midwifery Education, Poznan University of Medical Sciences, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalina","family":"Wi\u015bniewska","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland"},{"name":"Doctoral School, Poznan University of Medical Sciences, 60-812 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0864-3690","authenticated-orcid":false,"given":"Alicja","family":"Rzymska","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Society, Poznan University of Medical Sciences, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-907X","authenticated-orcid":false,"given":"Bart\u0142omiej","family":"Burzy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9911-2448","authenticated-orcid":false,"given":"Pawe\u0142","family":"Rzymski","sequence":"additional","affiliation":[{"name":"Department of Mother\u2019s and Child\u2019s Health, Gynecologic and Obstetrical University Hospital, Poznan University of Medical Sciences, Polna St 33, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcsm.12525","article-title":"Nutrition interventions to treat low muscle mass in cancer","volume":"11","author":"Prado","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcsm.12468","article-title":"Sarcopenia and ovarian cancer survival: A systematic review and meta-analysis","volume":"10","author":"Ubachs","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lin, W.-L., Nguyen, T.-H., Lin, C.-Y., Wu, L.-M., Huang, W.-T., and Guo, H.-R. (2023). Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1037796"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Correction to: Sarcopenia: Revised European Consensus on Definition and Diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_5","first-page":"4544","article-title":"Impact of sarcopenia and low muscle attenuation on outcomes of ovarian cancer: A systematic review and meta-analysis","volume":"27","author":"Ge","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/IGC.0000000000000867","article-title":"Sarcopenia in Advanced Serous Ovarian Cancer","volume":"27","author":"Bronger","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1158\/1078-0432.CCR-18-0788","article-title":"Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer","volume":"24","author":"Lee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_9","first-page":"524","article-title":"Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer","volume":"73","author":"Rodrigues","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.29271\/jcpsp.2021.11.1314","article-title":"Impact of Muscle Mass Depletion on Surgical Outcomes in Patients with Primary High-grade Serous Ovarian Cancer Undergoing CRS and HIPEC","volume":"31","author":"Mercan","year":"2021","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2021.05.039","article-title":"Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer","volume":"162","author":"Viddeleer","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3346\/jkms.2021.36.e2","article-title":"Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer","volume":"36","author":"Chae","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejso.2016.12.016","article-title":"The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery","volume":"43","author":"Rutten","year":"2017","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/ijgc-2020-001678","article-title":"A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy","volume":"30","author":"Allanson","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_15","first-page":"108403","article-title":"Sarcopenia in gynaecological cancers","volume":"51","author":"Suleiman","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jcsm.12107","article-title":"Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients","volume":"7","author":"Rutten","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcsm.12267","article-title":"Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer","volume":"9","author":"Daly","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body Composition as an Independent Determinant of 5-Fluorouracil\u2013Based Chemotherapy Toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/1078-0432.CCR-16-2266","article-title":"Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane\u2013Based Chemotherapy for Early-Stage Breast Cancer","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102108","DOI":"10.1016\/j.ijgc.2025.102108","article-title":"Body composition as a predictive factor for chemotherapy-induced peripheral neuropathy and dose-limiting toxicity in patients with endometrial cancer undergoing carboplatin and paclitaxel","volume":"35","author":"Aichi","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sbrignadello, S., G\u00f6bl, C., and Tura, A. (2022). Bioelectrical Impedance Analysis for the Assessment of Body Composition in Sarcopenia and Type 2 Diabetes. Nutrients, 14.","DOI":"10.3390\/nu14091864"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70362","DOI":"10.1111\/jog.70362","article-title":"Impact of Sarcopenia and Pretreatment Skeletal Muscle Loss on Survival in Endometrial Cancer Patients Treated with Immune Checkpoint Inhibitors","volume":"52","author":"Katayama","year":"2026","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_24","first-page":"267","article-title":"Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy","volume":"31","author":"Lee","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jcsm.12499","article-title":"The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer","volume":"11","author":"Daly","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/01635581.2018.1513046","article-title":"Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review","volume":"71","author":"Inglis","year":"2019","journal-title":"Nutr. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/1750743X.2025.2525743","article-title":"Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors","volume":"17","author":"Sahin","year":"2025","journal-title":"Immunotherapy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/jcsm.13183","article-title":"Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer","volume":"14","author":"Kim","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103288","DOI":"10.1016\/j.clnesp.2026.103288","article-title":"Albumin-myosteatosis gauge as predictor of survival time in patients with lung cancer treated with immune checkpoint inhibitors","volume":"73","author":"Wei","year":"2026","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1038\/s41598-024-71878-2","article-title":"Comparative analysis of body composition using torso CT from PET\/CT with bioelectrical impedance and muscle strength in healthy adults","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:30:50Z","timestamp":1790843450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":31,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193164"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193164","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}